BDULF

Bangkok Dusit Medical Services Public Company Limited BDULF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BDULF MTHRF MTHRY SHPMY GIFLF GIFOF SHPMF ORINF BIOVF KYKOF
6M -10.00 % 53.13 % 16.23 % 20.50 % 63.53 % 6.85 % -1.92 % 67.11 % 23.33 % 16.14 %
YTD -25.88 % 73.72 % 66.13 % -1.32 % 45.55 % 26.29 % -5.56 % 67.11 % 17.67 % 14.20 %
1Y -13.70 % 41.87 % 25.83 % 6.74 % 24.00 % 4.07 % -90.84 % 111.83 % 12.88 % -2.11 %
3Y -17.31 % -48.61 % -47.97 % 16.90 % 75.95 % 54.65 % -88.14 % 101.79 % 78.07 % -25.33 %
5Y -11.74 % -78.76 % -79.14 % 2.24 % -54.99 % -53.61 % -90.13 % 84.44 % 72.27 % -33.73 %
10Y 16.67 % 42.53 % -66.08 % -22.58 % -31.70 % -71.56 % -40.70 % 130.97 % 72.27 % 2.88 %
From the beginning 404.00 % -45.81 % -66.08 % -34.37 % -99.93 % -66.48 % -92.88 % 228.48 % 72.27 % 217.22 %

Dividend

Bangkok Dusit Medical Services Public Company Limited

M3, Inc.

M3, Inc.

Shanghai Pharmaceuticals Holding Co., Ltd

Grifols, S.A.

Grifols, S.A.

Shanghai Pharmaceuticals Holding Co., Ltd

Orion Oyj

Kyowa Kirin Co., Ltd.